TSE:NBLY

Neighbourly Pharmacy (NBLY) Stock Forecast, Price & News

C$12.56

-0.22 (-1.72%)

(As of 05:13 PM ET)

Compare

Today's Range: C$12.50
▼
C$12.85
50-Day Range: C$12.78
▼
C$18.24
52-Week Range: C$12.50
▼
C$25.50

Volume: 34,240 shs
Average Volume: 39,178 shs
Market Capitalization: C$561.06 million

P/E Ratio: N/A
Dividend Yield: 1.43%
Price Target: C$24.50

Profile Analyst Ratings Chart Competitors Dividend Insider Trades Headlines Social Media

Neighbourly Pharmacy MarketRank™ Forecast

Analyst Rating: Moderate Buy
2.50 Rating Score
Upside/Downside: 95.1% Upside
C$24.50 Price Target
Short Interest: N/A
Dividend Strength: Weak
Based on Four Factors
Sustainability: N/A
News Sentiment: N/A
Insider Trading: N/A
Proj. Earnings Growth: N/A

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.06 out of 5 stars

3.3

Analyst's Opinion

Consensus Rating
Neighbourly Pharmacy has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 3 buy ratings, 3 hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of C$24.50, Neighbourly Pharmacy has a forecasted upside of 95.1% from its current price of C$12.56.
Amount of Analyst Coverage
Neighbourly Pharmacy has only been the subject of 4 research reports in the past 90 days.

N/A

Short Interest

Short Interest
There is no current short interest data available for NBLY.

0.8

Dividend Strength

Dividend Yield
Neighbourly Pharmacy pays a meaningful dividend of 1.28%, higher than the bottom 25% of all stocks that pay dividends.
Dividend Growth
Neighbourly Pharmacy does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for NBLY.

3.0

News and Social Media Coverage

News Sentiment
Neighbourly Pharmacy has a news sentiment score of 1.34. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.68 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 1 news article for Neighbourly Pharmacy this week, compared to 1 article on an average week.
Search Interest
2 people have searched for NBLY on MarketBeat in the last 30 days.

1.7

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Neighbourly Pharmacy insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 0.43% of the stock of Neighbourly Pharmacy is held by insiders.
Percentage Held by Institutions
70.73% of the stock of Neighbourly Pharmacy is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

0.6

Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of Neighbourly Pharmacy is -20.59, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Neighbourly Pharmacy is -20.59, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Neighbourly Pharmacy has a P/B Ratio of 0.94. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Neighbourly Pharmacy (TSE:NBLY) Stock

Neighbourly Pharmacy Inc. owns and operates a chain of retail pharmacies in Canada. The company sells prescription medication, confections and food, over the counter drugs, and health and beauty aids. It operates pharmacies under the various banners, such as IDA/Guardian, Pharmachoice, Pharmasave, Remedy's RX, and Drug Trading. The company was incorporated in 2015 and is headquartered in Toronto, Canada.

NBLY Price History

30 days | 90 days | 365 days | Advanced Chart

NBLY Stock News Headlines

September 29, 2023 | finance.yahoo.com

Neighbourly Recognized as One of Canada's Top Growing Companies in the Globe and Mail's Fifth-Annual Ranking

September 21, 2023 | americanbankingnews.com

Neighbourly Pharmacy Inc. (TSE:NBLY) Given Average Recommendation of "Moderate Buy" by Brokerages

September 29, 2023 | Chaikin Analytics (Ad)

Buy This Stock for AI Tidal Wave (not NVDA)

The internet boom made more millionaires than any tech - Microsoft’s CEO says AI has even more potential. Here’s the #1 stock to buy.

September 8, 2023 | finance.yahoo.com

While individual investors own 27% of Neighbourly Pharmacy Inc. (TSE:NBLY), private equity firms are its largest shareholders with 50% ownership

September 3, 2023 | ca.finance.yahoo.com

2 Stocks That Could Beat a Bear Market

August 25, 2023 | theglobeandmail.com

Closing Bell: Neighbourly Pharmacy Inc flat on Thursday (NBLY)

August 5, 2023 | finance.yahoo.com

Neighbourly Pharmacy (TSE:NBLY) Has Announced A Dividend Of CA$0.045

August 3, 2023 | markets.businessinsider.com

RBC Capital Maintains a Buy Rating on Neighbourly Pharmacy, Inc. (NBLY)

September 29, 2023 | Chaikin Analytics (Ad)

His system isolated NVIDIA - Here's His Next Buy.

Most investors don't know the truth about A.I. 50-year Wall Street Insider Marc Chaikin reveals what you should be doing to profit. Learn more here.

August 2, 2023 | markets.businessinsider.com

BMO Capital Keeps Their Hold Rating on Neighbourly Pharmacy, Inc. (NBLY)

August 2, 2023 | finance.yahoo.com

Neighbourly Announces Annual Meeting Results

August 1, 2023 | finance.yahoo.com

Neighbourly Announces Strong First Quarter Results

July 25, 2023 | finance.yahoo.com

Neighbourly Pharmacy Inc. (TSE:NBLY) Is About To Turn The Corner

July 21, 2023 | finance.yahoo.com

NBLY.TO - Neighbourly Pharmacy Inc.

July 13, 2023 | markets.businessinsider.com

RBC Capital Remains a Buy on Neighbourly Pharmacy, Inc. (NBLY)

July 7, 2023 | theglobeandmail.com

Closing Bell: Neighbourly Pharmacy Inc up on Thursday (NBLY)

July 5, 2023 | ca.finance.yahoo.com

1 TSX Bargain Stock I’m Adding to My Basket

June 30, 2023 | finance.yahoo.com

Four Days Left Until Neighbourly Pharmacy Inc. (TSE:NBLY) Trades Ex-Dividend

June 27, 2023 | finance.yahoo.com

Neighbourly: A Friendly Canadian Pharmacy With Value Potential

June 18, 2023 | finance.yahoo.com

Stuart Elman Buys Handful Of Shares In Neighbourly Pharmacy

June 12, 2023 | theglobeandmail.com

Closing Bell: Neighbourly Pharmacy Inc down on Monday (NBLY)

June 9, 2023 | msn.com

TD SECURITIES Maintains Neighbourly Pharmacy (TSE:NBLY) Buy Recommendation

June 9, 2023 | markets.businessinsider.com

Neighbourly Pharmacy, Inc. (NBLY) Gets a Hold Rating from Desjardins

June 8, 2023 | finance.yahoo.com

Neighbourly Announces Strong Fourth Quarter and Full Year Results

June 6, 2023 | msn.com

Neighbourly agrees to acquire seven pharmacies in Western Canada

June 6, 2023 | finance.yahoo.com

Neighbourly Announces Agreement to Acquire Seven Pharmacies in Western Canada

June 1, 2023 | finance.yahoo.com

Neighbourly Appoints Alicia Matthews-Kent to Lead Pharmacy Strategy and Professional Affairs

See More Headlines

Receive NBLY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Neighbourly Pharmacy and its competitors with MarketBeat's FREE daily newsletter.

NBLY Company Calendar

Ex-Dividend for 8/3 Dividend: 7/05/2023
Dividend Payable: 8/03/2023
Ex-Dividend for 9/26 Dividend: 8/28/2023
Dividend Payable: 9/26/2023
Today: 9/29/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: TSE
Industry: Pharmaceutical Retailers
Sub-Industry: N/A
Sector: Medical
Current Symbol: TSE:NBLY
CUSIP: N/A
CIK: N/A
Web: neighbourlypharmacy.ca
Phone: 416 309 9102
Fax: N/A
Employees: 3,648
Year Founded: N/A

Price Target and Rating

Average Stock Price Forecast: C$24.50
High Stock Price Forecast: C$30.00
Low Stock Price Forecast: C$20.00
Forecasted Upside/Downside: +91.7%
Consensus Rating: Moderate Buy
Rating Score (0-4): 2.50
Research Coverage: 6 Analysts

Profitability

EPS (Most Recent Fiscal Year): C($0.61)
Trailing P/E Ratio: N/A
Forward P/E Ratio: 25.12
P/E Growth: N/A
Net Income: C$-26,610,000.00
Net Margins: -3.20%
Pretax Margin: N/A
Return on Equity: -5.46%
Return on Assets: 0.94%

Debt

Debt-to-Equity Ratio: 49.99
Current Ratio: 1.15
Quick Ratio: 0.75

Sales & Book Value

Annual Sales: C$831.61 million
Price / Sales: 0.69
Cash Flow: C$0.41 per share
Price / Cash Flow: 31.16
Book Value: C$13.42 per share
Price / Book: 0.95

Miscellaneous

Outstanding Shares: 44,670,000
Free Float: N/A
Market Cap: C$570.88 million
Optionable: Not Optionable
Beta: 0.57

20 Stocks to Sell Now

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Key Executives

Mr. Skip Bourdo (Age 46)
CEO & Director
Comp: $604.17k

Mr. Billy Wong C.M.A.
CPA, M.B.A., Chief Financial Officer

Mr. Jari Pekka Villanen (Age 52)
Sr. VP of Operations
Comp: $307.48k

Mr. Roy J. Wieschkowski (Age 60)
Sr. VP of People & Culture
Comp: $255.84k

Mr. Steve Losty (Age 49)
Chief Devel. Officer
Comp: $302.15k

Key Competitors

View All Competitors

Insiders

View All Insider Transactions

NBLY Stock - Frequently Asked Questions

Should I buy or sell Neighbourly Pharmacy stock right now?: 6 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Neighbourly Pharmacy in the last twelve months. There are currently 3 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" NBLY shares.
View NBLY analyst ratings or view top-rated stocks.
What is Neighbourly Pharmacy's stock price forecast for 2023?: 6 brokerages have issued twelve-month target prices for Neighbourly Pharmacy's shares. Their NBLY share price forecasts range from C$20.00 to C$30.00. On average, they predict the company's stock price to reach C$24.50 in the next year. This suggests a possible upside of 91.7% from the stock's current price.
View analysts price targets for NBLY or view top-rated stocks among Wall Street analysts.
How have NBLY shares performed in 2023?: Neighbourly Pharmacy's stock was trading at C$23.39 at the start of the year. Since then, NBLY shares have decreased by 45.4% and is now trading at C$12.78.
View the best growth stocks for 2023 here.
How often does Neighbourly Pharmacy pay dividends? What is the dividend yield for Neighbourly Pharmacy?: Neighbourly Pharmacy announced a quarterly dividend on Monday, August 28th. Shareholders of record on Tuesday, September 26th will be given a dividend of 0.045 per share on Tuesday, September 26th. This represents a $0.18 annualized dividend and a dividend yield of 1.41%. The ex-dividend date of this dividend is Monday, August 28th.
Read our dividend analysis for NBLY.
Is Neighbourly Pharmacy a good dividend stock?: Neighbourly Pharmacy (TSE:NBLY) pays an annual dividend of C$0.18 per share and currently has a dividend yield of 1.28%.
Read our dividend analysis for NBLY.

What is Neighbourly Pharmacy's stock symbol?: Neighbourly Pharmacy trades on the Toronto Stock Exchange (TSX) under the ticker symbol "NBLY."
How do I buy shares of Neighbourly Pharmacy?: Shares of NBLY stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.
What is Neighbourly Pharmacy's stock price today?: One share of NBLY stock can currently be purchased for approximately C$12.78.
How much money does Neighbourly Pharmacy make?: Neighbourly Pharmacy (TSE:NBLY) has a market capitalization of C$570.88 million and generates C$831.61 million in revenue each year. The company earns C$-26,610,000.00 in net income (profit) each year or C($0.61) on an earnings per share basis.
How many employees does Neighbourly Pharmacy have?: The company employs 3,648 workers across the globe.
How can I contact Neighbourly Pharmacy?: Neighbourly Pharmacy's mailing address is 190 Attwell Drive, Unit 400, Toronto, ON M9W 6H8, Canada. The official website for the company is neighbourlypharmacy.ca. The company can be reached via phone at 416 309 9102.

This page (TSE:NBLY) was last updated on 9/29/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Neighbourly Pharmacy (NBLY) Stock Forecast, Price & News

Neighbourly Pharmacy MarketRank™ Forecast

Overall MarketRank™

Analyst's Opinion

Short Interest

Short Interest

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

News and Social Media Coverage

News Sentiment

News Coverage This Week

Search Interest

Company Ownership

Earnings and Valuation

About Neighbourly Pharmacy (TSE:NBLY) Stock

NBLY Price History

NBLY Stock News Headlines

NBLY Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

Insiders

NBLY Stock - Frequently Asked Questions

Overall MarketRank^™